Posted by Michael Wonder on 22 Jan 2024
Generic drugs in the US are too cheap to be sustainable, experts say
19 January 2024 - Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business.
Drug prices regularly spark recrimination and outrage on Capitol Hill, such as a recently announced investigation by Senate Democrats and Bernie Sanders into the price of albuterol inhalers.
“There is no rational reason, other than greed, as to why GlaxoSmithKline charges $319 for Advair HFA in the United States, but just $26 for the same inhaler in the United Kingdom,” Sanders said in a statement.
